An in vivo assessment of Adriamycin-loaded albumin microspheres
1992

Adriamycin-Loaded Albumin Microspheres in Cancer Treatment

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): J.A. Goldberg, N. Willmott, D.J. Kerr, C. Sutherland, C.S. McArdle

Primary Institution: University Departments of Surgery and Pathology, Royal Infirmary, Glasgow; Department of Pharmacy, University of Strathclyde, Glasgow; Cancer Research Campaign Department of Clinical Oncology, University of Glasgow, UK.

Hypothesis

The study aims to assess the anti-tumour effect of Adriamycin-loaded albumin microspheres given regionally in a rat tumour model.

Conclusion

Adriamycin-loaded albumin microspheres can suppress tumour growth more effectively than Adriamycin in solution.

Supporting Evidence

  • The mean tumour weight at cull was significantly lower in the group treated with Adriamycin-loaded albumin microspheres.
  • Fluorescent microscopy detected considerable amounts of Adriamycin in the liver and tumour of animals treated with drug-loaded microspheres.
  • Intracellular Adriamycin was demonstrated in the tumour and liver of animals which had received the drug-loaded particles.

Takeaway

This study shows that special tiny balls filled with a cancer drug can help fight tumors better than just giving the drug in liquid form.

Methodology

The study used a rat model with hepatic tumour implants and compared the effects of different treatments via intra-arterial administration.

Limitations

The study was conducted in an animal model, which may not fully represent human responses.

Participant Demographics

Sprague-Dawley rats, 600-700 g, with hepatic tumour implants.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication